← Back to headlines
Replimune's Advanced Skin Cancer Drug Fails FDA Approval Again
Replimune's drug designed to treat advanced skin cancer has once again failed to receive approval from the FDA.
10 Apr, 16:12 — 10 Apr, 16:12
Sources
Showing 1 of 1 sources
Related Stories
It completely changes the way you think: The phenomenon that astronauts experience in space and changes their lives
9m ago
Artemis II crew set for splashdown after historic lunar flyby
15m ago
What will happen during the final hours of the Artemis II mission?
23m ago
Sperm Whale Washes Ashore in Iceland
57m ago